Mark Sandbaken
Keine laufenden Positionen mehr
Profil
Dr. Mark Sandbaken is Vice President-Intellectual Property at Seattle Genetics, Inc.
He received his undergraduate degree from Carleton College, a graduate degree from the S.J.
Quinney College of Law, and a doctorate degree from the University of Wisconsin.
Ehemalige bekannte Positionen von Mark Sandbaken
| Unternehmen | Position | Ende |
|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | - |
Ausbildung von Mark Sandbaken
| University of Wisconsin | Doctorate Degree |
| Carleton College | Undergraduate Degree |
| S.J. Quinney College of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
